how many people are taking glp-1 for weight loss Poll: 1 in 8 Adults Say They've Taken a Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease Chart: 1 in 8 Americans

Accessed December 14, 2022

1-2 , 1-3 , Q

GLP-1 receptor agonists, and related dual GIP/GLP-1 agonists, are injectable or oral medications that mimic hormones involved in blood sugar control and appetite

It works on brain chemicals like dopamine, norepinephrine, and serotonin, helping users feel fuller faster and for longer

The molecule was developed by Frank Ng's group at Monash University and Metabolic Pharmaceuticals in Australia during the 1990s and 2000s as a potential anti-obesity drug intended to isolate the lipolytic region of hGH without activating the growth hormone receptor or raising IGF-1.nnIn published preclinical work, the fragment has been shown to stimulate lipolysis, suppress lipogenesis, and modulate the beta-3 adrenergic receptor pathway in adipose tissue rather than acting through the classical hGH receptor